期刊文献+

肝癌患者高表达神经细胞黏附分子L1预后差 被引量:2

High level of L1CAM predicting poor prognosis in hepatocellular carcinoma patients
下载PDF
导出
摘要 目的神经细胞黏附分子L1(L1CAM)在肝癌中的表达及其与临床预后的关系。方法对110例肝癌样本用Western blot及qRT-PCR方法检测L1CAM蛋白和mRNA的表达,分析了L1CAM表达与肝癌患者总体生存率的关系。结果肝癌组织L1CAM蛋白、mRNA表达水平显著高于对应非肿瘤组织(P<0.01);在中-低分化肝癌患者L1CAM表达量高于高分化肝癌患者(P<0.01);L1CAM mRNA的表达与肿瘤的分化程度、TNM分期密切相关(P<0.05);采用Kaplan-Meier法生存分析,高表达L1CAM患者预后差(P<0.01)。结论 L1CAM与肝癌的发生、发展具有相关性,或许可作为评估肝癌患者预后的指标之一。 Objective To investigate the clinical significance and prognostic value of PKD3 expression in human hepatocellu- lar carcinoma (HCC) after hepatectomy. Methods We analyzed mRNA expression of L1CAM in 110 HCCs by quantitative real- time PCR (qRT-PCR) and western blot,and the relationship among the overall survival of HCCs. Results The relative protein and mRNA expression level of L1CAM was up-regulated in HCCs comparing with adjacent non tumor liver tissues (P〈0.01). L1CAM expression in the well-differentiated group was higher than that in the poor-differentiated group (P〈0.01). The expression of L1CAM mRNA was significantly correlated with tumor differentiation and TNM stage (P〈0.05). The prognosis of patients with high expression L1CAM was poor (P〈0.01). Conclusion L1CAM expression is related to occurrence and development of HCCs and may predict the prognosis of HCCs after hepatectomy.
出处 《重庆医学》 CAS 北大核心 2015年第22期3055-3057,共3页 Chongqing medicine
关键词 肝细胞 神经细胞黏附分子L1 预后 carcinoma,hepatocellular neural cell adhesion molecule Ll prognosis
  • 相关文献

参考文献14

  • 1El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med,2011,365(12) :1118-1127.
  • 2Parkin DM, Pisani P, Ferlay J. Global cancer statistics[J]. CA Cancer J Clin,1999,49(1) :33-64.
  • 3European Association for Study of Liver, European Or- ganisation for Research and Treatment of Cancer. EASL- EORTC clinical practice guidelines:management of hepa- tocellular carcinoma[J].Eur J Cancer, 2012,48 (5) : 599- 641.
  • 4Tsuzuki T,Izumoto S, Ohnishi T, et al. Neural cell adhe- sion molecule Ll in gliomas: correlation with TGF-beta and p53[J].J Clin Pathol, 1998,51 (1) : 13-17.
  • 5Zechini S, Bianchi M, Colombo N, et al. The differential role of L1 in ovarian carcinoma and normal ovarian sur- face epithelium[J]. Cancer Res,2008,68(4) :1110-1118.
  • 6Bergmann F, Wandschneider F, Sipos BA, et al. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic duetal adenocarcinoma [J]. Oncol Rep, 2010,24 (4) : 909-915.
  • 7Lim KC, Chow P, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carci- noma within the Milan criteria[J]. Br J Surg, 2012,99 (12) : 1622-1629.
  • 8Takayama T. Surgical treatment for hepatocellular carci- noma[J]. Jpn J Clin Oncol,2011,41(4) :447-454.
  • 9Kiefel H, Bondong S, Hazin J, et al. LICAM A major driver for tumor cell invasion and motility[J]. Cell Adh Migr, 2012,6 (4) : 374-384.
  • 10Shtutman M,Levina E,Ohouo P,et al. Cell adhesion mol- ecule L1 disrupts E-cadherin-containing adherens junc- tions and increases scattering and motility of MCF7 breast carcinoma cells [ J ]. Cancer Res, 2006, 66 ( 23 ) : 11370-11380.

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部